Skip to main content
. Author manuscript; available in PMC: 2016 Mar 31.
Published in final edited form as: Biol Blood Marrow Transplant. 2014 Oct 6;21(1):113–118. doi: 10.1016/j.bbmt.2014.09.028

Table 1.

Demographics of Patients Who Underwent Echocardiographic Screening on Day +7

Characteristic Abnormal Day +7
Echocardiography
(n = 30)		 Normal Day +7
Echocardiography
(n = 70)		 P
Male 18 (60%) 47 (67%) .765
Median age at day 0, yr (IQR) 6.8 (3.7–12.1) 5.2 (2.4–10.4) .098
Myeloablative preparative regimen 9 (30%) 33 (47%) .127
Diagnosis .414
  Malignancy 10 (33%) 28 (40%)
  Immunodeficiency 12 (40%) 24 (34%)
  Bone marrow failure 5 (17%) 16 (23%)
  Genetic/metabolic 2 (7%) 2 (3%)
  Benign hematology 1 (3%) 0
Stem cell source .338
  Bone marrow 21 (70%) 38 (54%)
  Cord 2 (7%) 8 (11%)
  PBSCs 7 (23%) 24 (34%)
Donor type .198
  Autologous 2 (7%) 14 (20%)
  Related donor 3 (10%) 9 (13%)
  Unrelated donor 25 (83%) 47 (67%)

IQR indicates interquartile range; PBSCs, peripheral blood stem cells. Demographics with associated outcomes: elevated RV pressure, PEF, and LV dysfunction. Statistics were performed with Wilcoxon ranked sums test and Fisher exact test.